Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms

被引:225
作者
Wongdee, Kannikar [1 ,2 ]
Charoenphandhu, Narattaphol [3 ]
机构
[1] Mahidol Univ, Fac Sci, Consortium Calcium & Bone Res COCAB, Bangkok 10400, Thailand
[2] Burapha Univ, Fac Allied Hlth Sci, Chon Buri 20131, Thailand
[3] Mahidol Univ, Fac Sci, Dept Physiol, Rama VI Rd, Bangkok 10400, Thailand
关键词
Bone remodeling; Bone strength; Diabetes; Fragility fracture; Insulin; Osteoblast; Osteoclast; Osteopenia; Osteoporosis; Pregnancy;
D O I
10.4239/wjd.v2.i3.41
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Osteoporosis, a global age-related health problem in both male and female elderly, insidiously deteriorates the microstructure of bone, particularly at trabecular sites, such as vertebrae, ribs and hips, culminating in fragility fractures, pain and disability. Although osteoporosis is normally associated with senescence and estrogen deficiency, diabetes mellitus (DM), especially type 1 DM, also contributes to and/or aggravates bone loss in osteoporotic patients. This topic highlight article focuses on DM-induced osteoporosis and DM/osteoporosis comorbidity, covering alterations in bone metabolism as well as factors regulating bone growth under diabetic conditions including, insulin, insulin-like growth factor-1 and angiogenesis. Cellular and molecular mechanisms of DM-related bone loss are also discussed. This information provides a foundation for the better understanding of diabetic complications and for development of early screening and prevention of osteoporosis in diabetic patients.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 71 条
[2]
Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia [J].
Adams, V ;
Lenk, K ;
Linke, A ;
Lenz, D ;
Erbs, S ;
Sandri, M ;
Tarnok, A ;
Gielen, S ;
Emmrich, F ;
Schuler, G ;
Hambrecht, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :684-690
[3]
Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc11-S011]
[4]
American Diabetes Association, 2010, WHAT IS GEST DIAB
[5]
Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice [J].
Amin, Ali H. ;
Abd Elmageed, Zakaria Y. ;
Nair, Devika ;
Partyka, Megan I. ;
Kadowitz, Philip J. ;
Belmadani, Souad ;
Matrougui, Khalid .
LABORATORY INVESTIGATION, 2010, 90 (07) :985-996
[6]
The molecular understanding of osteoclast differentiation [J].
Asagiri, Masataka ;
Takayanagi, Hiroshi .
BONE, 2007, 40 (02) :251-264
[7]
Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice [J].
Botolin, S ;
Faugere, MC ;
Malluche, H ;
Orth, M ;
Meyer, R ;
McCabe, LR .
ENDOCRINOLOGY, 2005, 146 (08) :3622-3631
[8]
Bowman B. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P347
[9]
Brown S. A., 2004, CLIN DIABETES, V22, P10, DOI [10.2337/diaclin.22.1.10, DOI 10.2337/DIACLIN.22.1.10]
[10]
A slow release formulation of insulin as a treatment for osteoarthritis [J].
Cai, L ;
Okumu, FW ;
Cleland, JL ;
Beresini, M ;
Hogue, D ;
Lin, Z ;
Filvaroff, EH .
OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (09) :692-706